Posts

China approves Medivir’s patent application for Fostrox

Medivir has already received patents for Fostrox in the EU, Japan, the US and a ...

Laurus Labs and IIT Kanpur partner for new gene therapy...

Laurus Labs will establish a GMP facility at IIT Kanpur’s Techno Park facility.

Overcoming regulatory issues with investigational medic...

For clinical trials operating across different counties, challenges with regulat...

STAT+: A chatbot that’s cautious about GPT, AI pronounc...

In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...

Mersana Hit With Another FDA Hold Linked to Patient Fat...

An additional FDA hold has been placed on Mersana Therapeutics in connection wit...

FDA approves Biostar’s Phase II/III plans with utidelon...

The company hopes to work with other partners to bring Utidelone to market.

Abu Dhabi DoH signs new deal to accelerate development ...

The deal will see expansion of research into genomic medicine and genetic diseases.

Verix boosts life science AI capabilities with start-up...

start-up.ai will be merged with Verix’s AI lab, and its co-founder and CEO Shaha...

FDA clears Genentech’s Columvi for adults with R/R DLBCL

Columvi is a CD20xCD3 T-cell engaging bispecific antibody designed to treat R/R ...

Tessa Therapeutics Hodgkin’s Lymphoma CAR-T therapy sho...

TT11X is an “off-the-shelf”, genetically modified cell therapy being trialed for...

ANeuroTech shares plans for major depressive disorder p...

The company plans to finish the round by September or October at the latest.

MSD’s Keytruda use in adenocarcinoma could be limited b...

This comes amongst various wins for Keytruda in recent years.

Race for universal flu vaccine ramps up as Osivax kicks...

The first patient has been dosed with Osivax’s broad-spectrum candidate in its P...

Avenge Bio secures FDA orphan drug designation for meso...

Pleural mesothelioma represents 85% of new mesothelioma cases, followed by perit...

Flamingo gets grant from VLAIO to accelerate RNA-focuse...

The grant comes after Flamingo announced a deal in March 2023 to merge its opera...

Testosterone supplementation not linked to heart attack...

Testosterone supplementation in men with low levels of the hormone did not incre...